GSA CAPITAL PARTNERS LLP - CORBUS PHARMACEUTICALS HLDGS ownership

CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 114 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q1 2020. The put-call ratio across all filers is 0.30 and the average weighting 0.3%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of CORBUS PHARMACEUTICALS HLDGS
ValueSharesWeighting
Q1 2022$275,000
-12.4%
517,806
+800.7%
0.04%0.0%
Q4 2019$314,000
+307.8%
57,488
+265.2%
0.04%
+270.0%
Q3 2019$77,000
-40.3%
15,742
-7.9%
0.01%
+42.9%
Q3 2018$129,000
-81.7%
17,100
-87.7%
0.01%
-80.0%
Q2 2018$704,000
+49.2%
139,500
+109.8%
0.04%
+20.7%
Q4 2017$472,000
-34.5%
66,500
-34.0%
0.03%
-40.8%
Q3 2017$721,000
+94.9%
100,800
+71.4%
0.05%
+104.2%
Q2 2017$370,00058,8000.02%
Other shareholders
CORBUS PHARMACEUTICALS HLDGS shareholders Q1 2020
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 3,738,925$23,555,00031.22%
Perceptive Advisors 1,232,500$7,764,0000.39%
IFP Advisors, Inc 1,001,025$6,306,0000.27%
WOODSTOCK CORP 55,489$350,0000.07%
Virtus ETF Advisers LLC 50,795$320,0000.05%
Dynamic Technology Lab Private Ltd 31,431$198,0000.04%
Evanson Asset Management, LLC 20,660$130,0000.03%
Artal Group S.A. 250,000$1,575,0000.03%
GSA CAPITAL PARTNERS LLP 58,800$370,0000.02%
Raymond James Financial Services Advisors, Inc. 426,280$2,686,0000.02%
View complete list of CORBUS PHARMACEUTICALS HLDGS shareholders